The skin: A mirror to the gut

International Journal of Colorectal Disease

Volumn 28, Issue 7, 2013, Pages 889-913

  Ghevariya, Vishal ^a   Singhal, Shashideep ^b   Anand, Sury ^b  

^a ELMHURST HOSPITAL CENTER   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

Dermatological disorders; Gastrointestinal disorders; Gut; Management; Skin

Indexed keywords

ALPHA INTERFERON; AMINOCAPROIC ACID; ANALGESIC AGENT; ANTIRETROVIRUS AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DESMOPRESSIN; DIPHENHYDRAMINE; ESTROGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; IRON; KAOLIN PECTIN; LIDOCAINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PACLITAXEL; PENICILLAMINE; PROGESTERONE; RITUXIMAB; STEROID; TETRACYCLINE; UNINDEXED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABLATION THERAPY; ACANTHOSIS NIGRICANS; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; AMYLOIDOSIS; ANAPHYLACTOID PURPURA; ANGIOOSTEOHYPERTROPHY SYNDROME; BANNAYAN RILEY RUVALCABA SYNDROME; BLUE RUBBER BLEB NEVUS; BULLOUS SKIN DISEASE; CARCINOID SYNDROME; CAUSAL ATTRIBUTION; CHOLANGITIS; COWDEN SYNDROME; CRONKHITE CANADA SYNDROME; DERMATITIS HERPETIFORMIS; DIARRHEA; DIET THERAPY; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM PERFORATION; DISEASE ASSOCIATION; DRUG MEGADOSE; DYSPHAGIA; EHLERS DANLOS SYNDROME; EPIDERMOLYSIS BULLOSA; EPIGASTRIC DISCOMFORT; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; ESOPHAGUS STENOSIS; FAMILIAL COLON POLYPOSIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GLUCAGONOMA SYNDROME; HEMOCHROMATOSIS; HUMAN; HYPERTRICHOSIS LANUGINOSA; INTESTINE BYPASS SYNDROME; INTUSSUSCEPTION; KAPOSI SARCOMA; LOW DRUG DOSE; MALIGNANT ATROPHIC PAPULOSIS; MASTOCYTOSIS; MELANOMA; MOUTH LESION; MUIR TORRE SYNDROME; NEUROFIBROMATOSIS; ODYNOPHAGIA; PARANEOPLASTIC PEMPHIGUS; PEMPHIGOID; PEMPHIGUS VULGARIS; PEUTZ JEGHERS SYNDROME; PHYSIOTHERAPY; PLASMAPHERESIS; POLYARTERITIS NODOSA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; PYODERMA; PYODERMA GANGRENOSUM; REFLUX ESOPHAGITIS; RENDU OSLER WEBER DISEASE; REVIEW; SCLERODERMA; SKIN CARE; SKIN DEFECT; SKIN DISEASE; SKIN MANIFESTATION; STEM CELL; STEVENS JOHNSON SYNDROME; STOMACH TUBE; TREATMENT INDICATION; VOMITING; WOUND CARE; ZINC DEFICIENCY;

EID: 84880709580     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1637-x     Document Type: Review

References (132)

1. Mirowski GW, Mark LA. Oral disease and oral-cutaneous manifestations of gastrointestinal and liver disease. In: Sleisenger and Fordtran's Gastrointestinal and liver disease. Volume 1. 8th ed. Philadelphia: Saunders, 2006: 443-463
2. KO CJ. Dermatologic manifestations of gastrointestinal disease. In: emedicine.medscape.com/article/1093801-overview.
3. Lorizzo M, Jorizzo JL. Skin lesions associated with gastrointestinal and liver diseases. In: Textbook of gastroenterology. Volume 2. 5th ed. Oxford: Wiley-Blackwell, 2009: 2755-2784.
4. Fine DJ (2010) Inherited epidermolysis bullosa. Orphanet J rare dis 5(1):12-28
5. Rook EA, Wilkinson DS, Ebling FJB et al. Epidermolysis bullosa. In: Textbook of dermatology. Volume 2. 8th ed. Oxford: Blackwell, 2010: 39.1-39.28.
6. Daniels TE, Quadra-White C (1981) Direct immunofluorescence in oral mucosal disease: a diagnostic analysis of 130 cases. Oral Surg Oral Med Oral Pathol 51(1):38-47
7. Korman NJ (2000) New and emerging therapies in the treatment of blistering diseases. Dermatol Clin 18(1):127-37, ix-x
8. Kasperkiewicz M, Schmidt E (2009) Current treatment of autoimmune blistering diseases. Curr Drug Discov Technol 6(4):270-280
9. Troiano M, Lotti T (2009) Rituximab in dermatological diseases. G Ital Dermatol Venerol 144(4):495-499
10. Zeina B, Kakka N, Mansoor S. Pemphigus vulgaris. In: emedicine.medscape. com/article/1064187-overview.
11. Goldberg LJ, Nisar N. Paraneoplastic pemphigus. In: emedicine.medscape. com/article/1064452-overview.
12. Anhalt GJ, Kim SC, Stanely JR et al (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323(5):1729-1735
13. Chapel TA, Chapel J (1996) Erythema multiforme. In: Tintinalli J et al (eds) Emergency medicine: a comprehensive study guide, 4th edn. McGraw Hill, New York, pp 1114-1116
14. Parrillo SJ. Stevens-Johnson Syndrome. In: emedicine.medscape.com/ article/756523-overview.
15. Yamane Y, Aihara M, Tatewaki S et al (2009) Analysis of treatments and deceased cases of severe adverse drug reactions - analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arerugi 58(5):537-47
16. Gilliand BC (1998) Systemic sclerosis. In: Braunwald E, Longo DL et al (eds) Harrison's principles of internal medicine, 14th edn. McGraw-Hill, New York, pp 1888-1895
17. Jimenez SA. Scleroderma. In: emedicine.medscape.com/article/331864- overview.
18. Wegener M, Adamek RJ, Wedmann B et al (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39(10):2209-15
19. Fries R, Shariat K, con Wilmowski et al (2005) Sildenafil in the treatment of Raynaud phenomenon resistant to vasodilator therapy. Circulation 112(19):2980-2985
20. Sallam H, McNearney TA, Doshi D et al (2007) Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients. Dig Dis Sci 52(5):1329-37
21. Westermark P, Benson MD, Buxbaum JM et al (2008) A primer of amyloid nomenclature. Amyloid 14(3):179-183
22. Kyle RA, Greipp PR (1983) Amyloidosis (AL): Clinical and laboratory features in 229 cases. Mayo Clin Proc 58(10):665-83
23. Ebert EC, Nagar M (2008) Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 103(3):776-87
24. Wong CK, Wang WJ (1994) Systemic amyloidosis: a report of 19 cases. Dermatology 189(1):47-51
25. Uitto J, Shamban A (1987) Heritable skin diseases with molecular defect in collagen or elastin. Dermatol Clin 5(1):63-84
26. Sahata T, Tsuda S, Abo M et al (2009) Ehlers-Danlos syndrome with a frequent intestinal perforation. Nippon Nalka Gakkai Zasshi 98(4):852-4
27. Beighton P (1972) The dominant and recessive forms of cutis laxa. J Med Genet 9(2):216-21
28. Mulvihill JJ, Parry DM, Sherman JL et al (1990) NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neuro-fibromatosis 2 (bilateral acoustic neurofibromatosis): an update. Ann Intern Med 113(1):39-52
29. DeBella K, Szudek J, Friedman JM (2000) Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105(3 Pt 1):608-614
30. Cameron AJ, Pairolero PC, Stanson AW et al (1982) Abdominal angina and neurofibromatosis. Mayo Clin Proc 57(2):125-8
31. Stamm B, Hedinger CE, Saremaslani P: Duodenal and ampullary carcinoid tumors: a report of 12 cases with pathological characteristics, polypeptide content, and relation to the MEN I syndrome and von Recklinghausen's disease (neurofibromatosis). Virchows Arch A Pathol Anat Histopathol; 408(5): 475-89
32. South CD, Baird MA, Marsh WL Jr (2009) Clinical challenges and images in GI. Ampullary somatostatinoma associated with neurofibromatosis type 1, presenting with iron-deficiency anemia. Gastroenterology 136(1):51-368
33. Hengge UR, Ruzicka T, Tyring SK et al (2002) Update on Kaposi's sarcoma and other HHV8 associated diseases. Part1: epidemiology, environment predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2(5):281-92
34. Gandhi M, Greenblatt RM (2002) Human herpes virus 8, Kaposi's sarcoma, and associated conditions. Clin Lab Med 22(4):883-910
35. Danzing JB, Brandt LJ, Reinus JF et al (1991) Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol 86(6):715-718
36. Parfitt JR, Rodriguez-Justo M, Feakins R et al (2008) Gastrointestinal Kaposi's sarcoma: CD 117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour. Histopathology 52(7):816-823
37. Schwartz RA. Osler-Weber-Rendu syndrome. In: emedicine.medscape.com/ article/1086114-overview.
38. Shovlin CL, Hughes JM, Scott J et al (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61(1):68-79
39. Kjeldsen AD, Kjeldsen J (2000) Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 95(2):415-418
40. Shields H, Shaffer K, O'farrell RP et al (2007) Gastrointestinal manifestations of dermatologic disorders. Clin Gastroenterol Hepatol 5(9):1010-7, quiz 1005-1006
41. Milot L, Kamaoui I, Gautier G et al (2008) Hereditary-hemorrhagic telangiectasia: one-step magnetic resonance examination in evaluation of liver involvement. Gastroenterol Clin Biol 32(8-9):677-685
42. Fritzler MJ, Arlette JP, Behm AR et al (1984) Hereditary hemorrhagic telangiectasia versus CREST syndrome: can serology aid diagnosis? J Am Acad Dermatol 10(2 Pt 1):192-6
43. Van Cutsem E, Rutgeerts P, Vantrappen G (1990) Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 335(8695):953-5
44. Longacre AV, Gross CP, Gallitelli M et al (2003) Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 98(1):59-65
45. Cherpelis BS. Fenske NA. Blue rubber bleb nevus syndrome. In: emedicine.medscape.com/article/1082839-overview.
46. Tyrrel RT, Baumgartner BR, Montemayor KA (1990) Blue rubber bleb nevus syndrome: CT diagnosis of intussusception. AJR Am J Roentgenol 154(1):105-6
47. Emami MH, Haghdani S, Tavakkoli H et al (2008) Endoscopic polypectomy resection of blue rubber bleb nevus lesions in small bowel. Indian J Gastroenterol 27(4):165-6
48. Scheinfeld NS. Degos disease. In: emedicine.medscape.com/article/1087180- overview.
49. High WA, Aranda J, Patel SB et al (2004) Is Degos disease a clinical and histological end point rather than a specific disease? J Am Acad Dermatol 50(6):895-899
50. Ball E, Newburger A, Ackerman AB (2004) Degos disease: a distinctive pattern of disease, chiefly of lupus erythematosus, and not a specific disease per se. Am J Dermatopathol 24(4):308-320
51. Guhl G, Diaz-Ley B, Delgado Y et al (2009) Wegener's granulomatosis: a new entity in the growing differential diagnosis of Degos' disease. Clin Exp Dermatol 34(5):e1-3
52. Degos R (1979) Malignant atrophic papulosis. Br J Dermatol 100(1):21-35
53. Magro C, Shapiro L, Johnson B et al. Rheumatology grand rounds hospital for special surgery (New York City) Degos Disease. Feb 10, 2010. In press.
54. Janniger CK (2006) Klippel-Trenaunay-Weber syndrome: differential diagnosis and workup. In: emedicine.medscape.com/article/1084257-overview. Int J Dermatol 45(8):883-90
55. Bliznak J, Staple TW (1974) Radiology of angiodysplasias of the limb. Radiology 110(1):35-44
56. Servelle M (1985) Klippel and Trenaunay's syndrome. 768 operated cases. Ann Surg 201(3):365-373
57. Baskerville PA, Ackroyd JS, Browse NL (1985) The etiology of the Klippel-Trenaunay syndrome. Ann Surg 202(5):624-627
58. McGrory BJ, Amadio PC (1993) Klippel-Trenaunay syndrome: orthopaedic considerations. Orthop Rev 22(1):41-50
59. Janniger CK. Klippel-Trenaunay-Weber syndrome. In: emedicine.medscape. com/article/1084257-overview.
60. Wang ZK, Wang FY, Zhu RM et al (2010) Klippel-Trenaunay syndrome with gastrointestinal bleeding, splenic hemangiomas and left inferior vena cava. World J Gastroenterol 16(12):1548-1552
61. Kocaman O, Alponat A, Aygun C et al (2009) Lower gastrointestinal bleeding, hematuria and splenic hemangiomas in Klippel-Trenaunay syndrome: a case report and literature review. Turk J Gastroenterol 20(1):62-6
62. Fakir E, Roberts T, Stephen L et al (2009) Klippel-Trenaunay-Weber syndrome: orodental manifestations and management considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107(6):754-8
63. Antoszczyk G, Obtulowicz A, Czarnobilska E et al (2008) Melkersson-Rosenthal syndrome - diagnostic and therapeutic problems. Przegl Lek 65(9):390-392
64. Boh EE (2002) Faleh al-smadei RM: Cutaneous manifestations of gastrointestinal diseases. Dermatol Clin 20(3):533-46
65. Zold E, Nagy A, Devenyi K et al (2009) Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: two birds with one stone. World J Gastroenterol 15(18):2293-5
66. Jorizzo JL (1985) Classification of urticaria and the reactive inflammatory vascular dermatoses. Dermatol Clin 3(1):3-12
67. White JW (1985) Erythema nodosum. Dermatol Clin 3(1):119-27
68. Philpot HC, Elewski BE, Banwell JG, Gramlich T (1992) Pyostomatitis vegetans and primary sclerosing cholangitis: markers of inflammatory bowel disease. Gastroenterology 103(2):668-74
69. Loftus EV. Inflammatory bowel disease: extraintestinal manifestations and cancer. In: Mayo clinic gastroenterology and hepatology board review. 3rd ed. Florence: Mayo Clinic Scientific Press, 2008: 218.
70. Ely PH (1980) The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol 2(6):473-87
71. Drenick EJ, Ahmed AR, Greenway F et al (1980) Cutaneous lesions after intestinal bypass. Ann Intern Med 93(4):557-9
72. Patton T, Jukic D, Juhas E (2009) Atypical histopathology in bowel-associated dermatosis-arthritis syndrome: a case report. Dermatol Online J 15(3):3
73. Kang W, Hao C, Nie Q (2009) Clinical challenges and images in GI. Sweet syndrome in association with ulcerative colitis. Gastroenterology 136(5):1507-1846
74. Yuchi H, Yamaga J, Ishikawa N et al (2000) Endoscopic appearance of the GI lesions associated with Sweet's syndrome. Gastrointest Endosc 52(2):287-9
75. Bodmer WF, Bailey CJ, Bodmer J et al (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328(6131):614-6
76. Schwartz RA. Gardner syndrome. In: emedicine.medscape.com/article/ 1084257-overview.
77. Tsao H (2000) Update on familial cancer syndromes and the skin. J Am Acad Dermatol 42(6):939-69, quiz 970-2
78. Lepisto A, Kiviluoto T, Halttunen J et al (2009) Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis. Endoscopy 41(6):504-9
79. Schwartz RA, Torre DP (1995) The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 33(1):90-104
80. Abbas O, Mahalingam M (2009) Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. J Cutan Pathol 36(6):613-9
81. Prieto VG. Muir-Torre syndrome. In: emedicine.medscape.com/article/ 1084257-overview.
82. Spielvogel RL, DeVillez RL, Roberts LC (1985) Oral isotretinoin therapy for familial Muir-Torre syndrome. J Am Acad Dermatol 12(3):475-480
83. Graefe T, Wollina U, Schulz H et al (2000) Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumor development. Dermatology 200(4):331-333
84. Starink TM (1984) Cowden's disease: analysis of fourteen new cases. J Am Acad Dermatol 11(6):1127-41
85. Liaw D, Marsh DJ, Li J et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16(1):64-67
86. Schaffer JV, Kamino H, Witkiewicz A et al (2006) Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome. Arch Dermatol 142(5):625-632
87. Requena L, Gutierrez J, Sanchez Yus E (1992) Multiple sclerotic fibromas of the skin. A cutaneous marker of Cowden's disease. J Cutan Pathol 19(4):346-351
88. Nishizawa A, Satoh T, Watanabe R et al (2009) Cowden syndrome: a novel mutation and overlooked glycogenic acanthosis in gingiva. Br J Dermatol 160(5):1116-8
89. Squarize CH, Castilho RM, Gutkind JS (2008) Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin. Cancer Res 68(17):7066-7072
90. Moreira AP, Feijo FS, Pinto JM et al (2009) Pseudoxanthoma elasticum. Dermatol Online J 15(1):9
91. Daniel ES, Ludwig SL, Lewin KJ et al (1982) The Cronkhite-Canada syndrome: an analysis of clinical and pathologic features and therapy in 55 patients. Medicine (Baltimore) 61(5):293-309
92. Russell DM, Bhathal PS (1983) St. John DJ: Complete remission in Cronkhite-Canada syndrome. Gastroenterology 85(1):180-5
93. Ferney DM, DeSchryver-Kecskemeti K, Clouse RE (1986) Treatment of Cronkhite-Canada syndrome with home total parenteral nutrition (letter). Ann Intern Med 104(4):588
94. Latiff ZA, Atmawidjaja RW, RajaLope RJ et al (2010) Bannayan Riley Ruvalcaba syndrome. AnnAcad Med Singapore 39(7):578-582
95. Jegher H, McKusick BA, Katz KH (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N Engl J Med 241(26):1037-36
96. Gammon A, Jsperson K, Kohlmann W et al (2009) Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol 23(2):219-231
97. Al-Thihli K, Palma L, Marcus V et al (2009) A case of Cowden's syndrome presenting with gastric carcinomas and gastrointestinal polyposis. Nat Clin Pract Gastroenterol Hepatol 6(3):184-9
98. Harb WJ, Sturgis EM. Differentiated thyroid cancer associated with intestinal polyposis syndromes: a review. Head Neck. 2009 Jun 17. [Epub ahead of print]
99. Harper PS, Harper RMJ, Howell-Evans AW (1970) Carcinoma of the esophagus with tylosis. Q J Med 39(155):317-33
100. Beyler AR, Yurdaydin C, Baher K et al (1996) Dilation therapy of upper esophageal webs in two cases of Plummer-Vinson syndrome. Endoscopy 28(2):266-7
101. Koklu S, Bulut M, Cakal B et al (2009) Gastric cancer presenting with Plummer-Vinson syndrome. J Am Geriatr Soc 57(5):933-4
102. Krawczyk M, Mykala-Ciesla J, Kolodziej-Jaskula A (2009) Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature. Pol Arch Med Wewn 119(3):180-3
103. Miller JH, Rapini RP. Acanthosis nigricans. In: emedicine.medscape.com/ article/1084257-overview.
104. Cohen PR, Grossman ME, Almeida L et al (1989) Tripe palms and malignancy. J Clin Oncol 7(5):669-78
105. Ghevariya V, Malieckal A, Ghevariya N et al (2009) Carcinoid tumors of gastrointestinal tract. South Med J 102(10):1032-1040
106. Zeitouni NC, Harvey N. Glucagonoma syndrome. In: emedicine.medscape.com/ article/1084257-overview.
107. Altimari AF, Bhoopalam N, O'Dorsio T et al (1986) Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Surgery 100(6):989-996
108. Nguyen VQ, Lewin WJ, Raugi GJ. Paraneoplastic diseases. In: emedicine.medscape.com/article/1084257-overview.
109. Hovenden AL (1993) Hypertrichosis lanuginose acquisita associated with malignancy. Clin Dermatol 11(1):99-106
110. Saad N, Hot A, Ninet J et al (2007) Acquired hypertrichosis lanuginose and gastric adenocarcinoma. Ann Dermatol Venereol 134(1):55-8
111. Montemarano AD, Forte GM. Henoch-Schonlein purpura. In: emedicine.medscape.com/article/1084257-overview.
112. Hogan DJ. Mastrodomenico CM. Mastocytosis. In: emedicine.medscape.com/ article/1084257-overview.
113. Kettelhut BV, Metcalfe DD (1991) Pediatric mastocytosis. J Invest Dermatol 96(3 Suppl):15S-18S, 60S-65S
114. Lee JK, Whittaker SJ, Enns RA (2008) Gastrointestinal manifestations of systemic mastocytosis. World J Gastroenterol 14(45):7005-8
115. Swetter SM. Malignant melanoma. In: emedicine.medscape.com/article/ 1084257-overview.
116. Schuchter LM, Green R, Fraker D (2000) Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol 12(2):181-5
117. Ollila DW, Essner R, Wanek LA et al (1996) Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 131(9):975-9-979-80
118. Drobnik J, Schwartz RA. Hemochromatosis. In: emedicine.medscape.com/ article/1084257-overview.
119. Barton JC, Acton RT (2009) Hemochromatosis and Vibrio vulnifucus wound infections. J Clin Gastroenterol 43(9):890-893
120. Dar FS, Faraj W, Zaman MB et al (2009) Outcome of liver transplantation in hereditary Hemochromatosis. Transpl Int 22(7):717-724
121. Poh-Fitzpatrick MB. Porphyria cutanea tarda: differential diagnoses and workup. In: emedicine.medscape.com/article/1103643-diagnosis.
122. Herrero C, Vicente A, Bruguera M et al (1993) Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 341(8848):788-9
123. Tsukazaki N, Watanable M, Irifune H et al (1998) Porphyria cutanea tarda and hepatitis C virus infection. Br J Dermatol 138(6):1015-7
124. Nunley JR. Dermatiologic manifestations of renal disease. In: emedicine.medscape.com/article/1084257-overview.
125. Kosmin DJ, Jackson JM. Polyarteritis nodosa. In: emedicine.medscape.com/ article/1084257-overview.
126. Ebert EC, Hagspiel KD, Nagar M et al (2008) Gastrointestinal involvement in polyarteritis nodosa. Clin Gastroenterol Hepatol 6(9):960-6
127. Zone J (2005) Skin manifestations of celiac disease. Gastroenterology 128(4 Suppl 1):S87-91
128. Miller JL. Dermatitis herpetiformis. In: emedicine.medscape.com/article/ 1084257-overview.
129. Abenavoli L, Proietti I, Leggio L (2006) Cutaneous manifestations in celiac disease. World J Gastroenterol 12(6):843-52
130. Jen M, Shah KN, Yan AC (2008) Cutaneous changes in nutritional diseases. In: Wolff K, Goldsmith LA, Katz SI et al (eds) Fitzpatrick's Dermatology in general medicine, 7th edn. McGraw Hill, New York, pp 1209-16
131. Kumar P, Lal NR, Mondal AK, Mondal A, Gharami RC, Maiti A (2012) Zinc and skin: a brief summary. Dermatol Online J 18(3):1
132. Wapnir RA (2000) Zinc deficiency, malnutrition and the gastrointestinal tract. J Nutr 130(5S Suppl):1388S-92S